Literature DB >> 28974775

Biochemical and cellular properties of insulin receptor signalling.

Rebecca A Haeusler1, Timothy E McGraw2, Domenico Accili3.   

Abstract

The mechanism of insulin action is a central theme in biology and medicine. In addition to the rather rare condition of insulin deficiency caused by autoimmune destruction of pancreatic β-cells, genetic and acquired abnormalities of insulin action underlie the far more common conditions of type 2 diabetes, obesity and insulin resistance. The latter predisposes to diseases ranging from hypertension to Alzheimer disease and cancer. Hence, understanding the biochemical and cellular properties of insulin receptor signalling is arguably a priority in biomedical research. In the past decade, major progress has led to the delineation of mechanisms of glucose transport, lipid synthesis, storage and mobilization. In addition to direct effects of insulin on signalling kinases and metabolic enzymes, the discovery of mechanisms of insulin-regulated gene transcription has led to a reassessment of the general principles of insulin action. These advances will accelerate the discovery of new treatment modalities for diabetes.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28974775      PMCID: PMC5894887          DOI: 10.1038/nrm.2017.89

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  244 in total

Review 1.  Critical nodes in signalling pathways: insights into insulin action.

Authors:  Cullen M Taniguchi; Brice Emanuelli; C Ronald Kahn
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

2.  Homozygosity for an allele encoding deacetylated FoxO1 protects macrophages from cholesterol-induced inflammation without increasing apoptosis.

Authors:  Kyoichiro Tsuchiya; Alexander S Banks; Chien-Ping Liang; Ira Tabas; Alan R Tall; Domenico Accili
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-09-22       Impact factor: 8.311

3.  The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling.

Authors:  Y Ebina; L Ellis; K Jarnagin; M Edery; L Graf; E Clauser; J H Ou; F Masiarz; Y W Kan; I D Goldfine
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

Review 4.  Insulin action and resistance in obesity and type 2 diabetes.

Authors:  Michael P Czech
Journal:  Nat Med       Date:  2017-07-11       Impact factor: 53.440

5.  Functional studies of Akt isoform specificity in skeletal muscle in vivo; maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression.

Authors:  Mark E Cleasby; Tracie A Reinten; Gregory J Cooney; David E James; Edward W Kraegen
Journal:  Mol Endocrinol       Date:  2006-10-04

6.  Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity.

Authors:  Lale Ozcan; Catherine C L Wong; Gang Li; Tao Xu; Utpal Pajvani; Sung Kyu Robin Park; Anetta Wronska; Bi-Xing Chen; Andrew R Marks; Akiyoshi Fukamizu; Johannes Backs; Harold A Singer; John R Yates; Domenico Accili; Ira Tabas
Journal:  Cell Metab       Date:  2012-04-12       Impact factor: 27.287

7.  Hormonal regulation of mouse fatty acid synthase gene transcription in liver.

Authors:  J D Paulauskis; H S Sul
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

8.  Akt regulates growth by directly phosphorylating Tsc2.

Authors:  Christopher J Potter; Laura G Pedraza; Tian Xu
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

9.  Dissection of the insulin signaling pathway via quantitative phosphoproteomics.

Authors:  Marcus Krüger; Irina Kratchmarova; Blagoy Blagoev; Yu-Hua Tseng; C Ronald Kahn; Matthias Mann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

10.  Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity.

Authors:  Naoto Kubota; Tetsuya Kubota; Eiji Kajiwara; Tomokatsu Iwamura; Hiroki Kumagai; Taku Watanabe; Mariko Inoue; Iseki Takamoto; Takayoshi Sasako; Katsuyoshi Kumagai; Motoyuki Kohjima; Makoto Nakamuta; Masao Moroi; Kaoru Sugi; Tetsuo Noda; Yasuo Terauchi; Kohjiro Ueki; Takashi Kadowaki
Journal:  Nat Commun       Date:  2016-10-06       Impact factor: 14.919

View more
  156 in total

Review 1.  Hepatic Insulin Clearance: Mechanism and Physiology.

Authors:  Sonia M Najjar; Germán Perdomo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

2.  Afadin is a scaffold protein repressing insulin action via HDAC6 in adipose tissue.

Authors:  Morten Lundh; Patricia Ss Petersen; Marie S Isidor; Dolly Nm Kazoka-Sørensen; Kaja Plucińska; Farnaz Shamsi; Cathrine Ørskov; Marco Tozzi; Erin L Brown; Emil Andersen; Tao Ma; Ulrich Müller; Romain Barrès; Viggo B Kristiansen; Zachary Gerhart-Hines; Yu-Hua Tseng; Brice Emanuelli
Journal:  EMBO Rep       Date:  2019-07-02       Impact factor: 8.807

3.  Differential effects of intrauterine growth restriction and a hypersinsulinemic-isoglycemic clamp on metabolic pathways and insulin action in the fetal liver.

Authors:  Amanda K Jones; Laura D Brown; Paul J Rozance; Natalie J Serkova; William W Hay; Jacob E Friedman; Stephanie R Wesolowski
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-02-13       Impact factor: 3.619

4.  Multi-dimensional Transcriptional Remodeling by Physiological Insulin In Vivo.

Authors:  Thiago M Batista; Ruben Garcia-Martin; Weikang Cai; Masahiro Konishi; Brian T O'Neill; Masaji Sakaguchi; Jong Hun Kim; Dae Young Jung; Jason K Kim; C Ronald Kahn
Journal:  Cell Rep       Date:  2019-03-19       Impact factor: 9.423

Review 5.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

Review 6.  The melanocortin pathway and control of appetite-progress and therapeutic implications.

Authors:  Giulia Baldini; Kevin D Phelan
Journal:  J Endocrinol       Date:  2019-04-01       Impact factor: 4.286

7.  Differential metabolic sensitivity of insulin-like-response- and TORC1-dependent overgrowth in Drosophila fat cells.

Authors:  Maelle Devilliers; Damien Garrido; Mickael Poidevin; Thomas Rubin; Arnaud Le Rouzic; Jacques Montagne
Journal:  Genetics       Date:  2021-03-03       Impact factor: 4.562

Review 8.  Hyperinsulinaemia in cancer.

Authors:  Emily J Gallagher; Derek LeRoith
Journal:  Nat Rev Cancer       Date:  2020-09-09       Impact factor: 60.716

9.  Effects of chronic hyperinsulinemia on metabolic pathways and insulin signaling in the fetal liver.

Authors:  Paul J Rozance; Amanda K Jones; Stephanie L Bourque; Angelo D'Alessandro; William W Hay; Laura D Brown; Stephanie R Wesolowski
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-08-24       Impact factor: 4.310

10.  The Yin and Yang function of microRNAs in insulin signalling and cancer.

Authors:  Juanhong Liu; Feng Liu
Journal:  RNA Biol       Date:  2020-08-13       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.